Asymmetric Security | $4,200,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Atlas Invest | $25,000,000 | (Jan 22, 2026)
Certified by Founder
Lodge
TRIMTECH Therapeutics Limited
start up
United Kingdom
- Cambridge, England
- 07/03/2025
- Seed
- $31,000,000
TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs and TRIMGLUEs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
- Industry Biotechnology Research
- Website https://trimtechtherapeutics.com/
- LinkedIn https://www.linkedin.com/company/trimtech-therapeutics-limited/
One to One Health | $12,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)